CervoMed (CRVO) Payables (2022 - 2025)
CervoMed (CRVO) has disclosed Payables for 9 consecutive years, with $1.5 million as the latest value for Q4 2025.
- Quarterly Payables fell 3.79% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, down 3.79% year-over-year, with the annual reading at $1.5 million for FY2025, 3.79% down from the prior year.
- Payables hit $1.5 million in Q4 2025 for CervoMed, up from $1.3 million in the prior quarter.
- In the past five years, Payables ranged from a high of $12.5 million in Q4 2022 to a low of $533790.0 in Q3 2023.
- Historically, Payables has averaged $1.8 million across 4 years, with a median of $951941.0 in 2023.
- Biggest five-year swings in Payables: plummeted 94.71% in 2023 and later skyrocketed 173.72% in 2025.
- Year by year, Payables stood at $12.5 million in 2022, then tumbled by 94.71% to $662471.0 in 2023, then skyrocketed by 128.15% to $1.5 million in 2024, then dropped by 3.79% to $1.5 million in 2025.
- Business Quant data shows Payables for CRVO at $1.5 million in Q4 2025, $1.3 million in Q3 2025, and $1.8 million in Q2 2025.